Related references
Note: Only part of the references are listed.Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland
Andrew G. Affleck et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation
G. B. E. Jemec et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Topical treatment of psoriasis
Philip M. Laws et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial
Stephen Tyring et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)
Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: An immunohistochemical study
Haike M. J. van der Velden et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2010)
Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial
K. Kragballe et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial
P. C. M. van de Kerkhof et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Calcipotriene/betamethasone in the treatment of psoriasis: a review article
Rosita Saraceno et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial
J. P. Ortonne et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Microcirculatory modifications of psoriatic lesions during topical therapy
Paolo Rosina et al.
SKIN RESEARCH AND TECHNOLOGY (2009)
Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: A phase II study
Colin Buckley et al.
DERMATOLOGY (2008)
A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis
T. A. Luger et al.
DERMATOLOGY (2008)
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial
Gregor B. E. Jemec et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Psoriasis: consensus on topical therapies
P. C. M. van de Kerkhof et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Psoriasis: advances in pathophysiology and management
A. MacDonald et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland
Julia M. Bottomley et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Psoriasis 1 - Pathogenesis and clinical features of psoriasis
Christopher E. M. Griffiths et al.
LANCET (2007)
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
A. Nast et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product
Nicoletta Cassano et al.
ACTA DERMATO-VENEREOLOGICA (2007)
Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany
M. Augustin et al.
DERMATOLOGY (2007)
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet (R)) versus calcipotriol (Daivonex (R)) in the treatment of psoriasis vulgaris: A randomized, multicentre, clinical trial
Rosita Saraceno et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2007)
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris
K. Kragballe et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Calcipotriol/betamethasone dipropionate for the treatment of psoriasis
A Charakida et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet (R)/Dovobet (R)/Taclonex (R)) in the treatment of psoriasis vulgaris
K. Kragballe et al.
DERMATOLOGY (2006)
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of psoriasis vulgaris
P Peeters et al.
DERMATOLOGY (2005)
Objective assessment of compliance with psoriasis treatment
SS Zaghloul et al.
ARCHIVES OF DERMATOLOGY (2004)
The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis
WHPM Vissers et al.
EXPERIMENTAL DERMATOLOGY (2004)
The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet®/Dovobet®) on the quality of life in patients with psoriasis vulgaris:: a randomized controlled trial
PCM van de Kerkhof
BRITISH JOURNAL OF DERMATOLOGY (2004)
Bioavailability of betamethasone dipropionate when combined with calcipotriol
J Traulsen
INTERNATIONAL JOURNAL OF DERMATOLOGY (2004)
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: A randomised, double-blind trial
JP Ortonne et al.
DERMATOLOGY (2004)
Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris
K Kragballe et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Calcipotriol/betamethasone dipropionate - A review of its use in the treatment of psoriasis vulgaris
C Fenton et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2004)
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis
KA Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment
J Traulsen et al.
DERMATOLOGY (2003)
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial
L Guenther et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
A new calcipotriol/beta methasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris
WS Douglas et al.
ACTA DERMATO-VENEREOLOGICA (2002)
A new calcipotriol/betamethasone dipropionate formulation (Daivobet (TM)) is an effective once-daily treatment for psoriasis vulgaris
R Kaufmann et al.
DERMATOLOGY (2002)
Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: A flow cytometric study
MM van Rossum et al.
DERMATOLOGY (2001)
Share Paper
